Laval, QC
Labopharm is an emerging pharmaceutical company whose goal is to become a leading supplier of controlled-release systems to the pharmaceutical industry worldwide. Its core platform technology, Contramid, applies to a wide range of medications in solid dosage forms to improve their oral administration and performance.
Contramid is patented and provides a means to add economic value to existing products or new chemical entities (NCEs), through extended patent protection and/or better product differentiation.
Labopharm Inc. (TSX: DDS, NASDAQ: DDSS) is an international, specialty pharmaceutical company focused on the development of drugs incorporating Contramid, the Companys proprietary advanced controlled-release technology. In the last years, Labopharm signed mutiple licensing agreements with international pharmaceutical companies to market on the US, Europe & Latin America a pain controlled-release product developed by Labopharm Inc.
Labopharm is located in the greater Montreal area and benefits from the region's well-established pharmaceutical infrastructure which provides access to a number of recognized contract research and contract manufacturing organizations, as required, as well as a favourable tax environment.
480 Armand-Frappier Blvd
Laval, QC H7V 4B4
CA
480 Armand-Frappier Blvd
Laval, QC H7V 4B4
CA
Legal Name: Labopharm Inc.
Number of Employees: 35
Total Sales ($CDN): $100,000 - $200,000
CA
Title: Vice President
Area of Responsibility: Management Executive
Phone: Show phone
Fax: Show fax
Email: Show email
Title: Vice President
Area of Responsibility: Research/Development/Engineering
Phone: Show phone
Fax: Show fax
Email: Show email
Title: Vice President
Area of Responsibility: Management Executive
Phone: Show phone
Fax: Show fax
Email: Show email
325410
United Kingdom, United States
Brazil, Japan